Efficacy of ME1036 against meticillin-resistant Staphylococcus aureus and vancomycin-insensitive S. aureus in a model of haematogenous pulmonary infection.
スポンサーリンク
概要
- 論文の詳細を見る
ME1036, a novel parenteral carbapenem, was developed for the treatment of meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-intermediate S. aureus (VISA). A model of haematogenous pulmonary infection was induced in mice by tail vein injection of MRSA strain NUMR101 or VISA Mu50 enmeshed in agar beads. After 24h of infection, mice were treated twice daily for 7 days with 200mg/kg/day vancomycin (VCM) or ME1036. Mice infected with VISA were also pre-treated with cyclophosphamide to induce an immunocompromised state. The number of viable bacteria in the lungs was counted 12h after the final drug treatment. VCM decreased the number of viable MRSA in the lungs in comparison with the control, although the difference was not significant (mean+/-standard error of the mean log(10) colony-forming units (CFU)/lung=6.876+/-0.54 vs. 8.25+/-0.41, respectively). In contrast, treatment with ME1036 resulted in a significant decrease in the number of viable MRSA (log(10)CFU/lung=2.69+/-0.44 (n=6); P<0.0001) compared with both the VCM-treated and control mice. In the VISA-infected mice, ME1036 significantly reduced the number of viable bacteria compared with VCM and control (log(10)CFU/lung=3.65+/-0.68 for ME1036 vs. 5.71+/-0.75 for VCM (P<0.05) and 7.07+/-0.45 for control (P<0.001)). ME1036 produced >3 log(10) reduction versus control against both MRSA strains (>5 log for the VCM-susceptible strain and 3.4 log for the VISA), whereas VCM produced <1.3 log for both strains.
論文 | ランダム
- 「被服構成及び実習」の授業におけるコンピュータ活用試案 : 東レアパレル・コンピュータ研修参加報告より
- 双曲型方程式に対するE.E. Leviの条件について (函数解析的方法による解析学研究会報告集)
- Le Probleme de Cauchy a Caracteristiques Multiples : Methode Directe de Trouver la Condition (Generalisee) de E.E. Levi (PARTIAL DIFFERENTIAL EQUATIONS AND THEIR APPLICATIONS)
- 現代のブラジル社会と対称詞の体系
- 続19世紀のブラジル社会と対称詞の体系 : 話者の感情変化と対称詞の変換(学校法人 京都外国語大学創立40周年記念号)